Post by Brandon Capital

Name: 📢 A great milestone for ENA Respiratory, with two new USPTO Notices of Allowance strengthening prot
Uploaded: 2026-06-16T06:15:35.445Z
Channel: Brandon Capital
Description: 📢 A great milestone for ENA Respiratory, with two new USPTO Notices of Allowance strengthening protection around its TLR2 agonist platform and lead candidate, INNA-051. As ENA Respiratory advances

11,297 followers

📢 A great milestone for ENA Respiratory, with two new USPTO Notices of Allowance strengthening protection around its TLR2 agonist platform and lead candidate, INNA-051. As ENA Respiratory advances its Phase II clinical program, this achievement further reinforces the value of its innovative approach to respiratory viral infections. Congratulations to Christophe Demaison and the ENA Respiratory team Read the press release in full below: A great milestone for ENA Respiratory, with two new USPTO Notices of Allowance strengthening protection around its TLR2 agonist platform and lead candidate, INNA-051. As ENA Respiratory advances its Phase II clinical program, this achievement further reinforces the value of its innovative approach to respiratory viral infections. Congratulations to Christophe Demaison and the ENA Respiratory team. Read the press release in full below: https://lnkd.in/gfpaa-mP #PortfolioNews #Biotech #LifeSciences #Innovation

Video Content